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Abstract
Background: Salmonella enterica is an important emerging cause of invasive infections worldwide. However, 
population-based data are limited. The objective of this study was to define the occurrence of S. enterica bacteremia in 
a large international population and to evaluate temporal and regional differences.
Methods: We conducted population-based laboratory surveillance for all salmonella bacteremias in six regions 
(annual population at risk 7.7 million residents) in Finland, Australia, Denmark, and Canada during 2000-2007.
Results: A total of 622 cases were identified for an annual incidence of 1.02 per 100,000 population. The incidence of 
typhoidal (serotypes Typhi and Paratyphi) and non-typhoidal (other serotypes) disease was 0.21 and 0.81 per 100,000/
year. There was major regional and moderate seasonal and year to year variability with an increased incidence 
observed in the latter years of the study related principally to increasing rates of non-typhoidal salmonella bacteremias. 
Advancing age and male gender were significant risk factors for acquiring non-typhoidal salmonella bacteremia. In 
contrast, typhoidal salmonella bacteremia showed a decreasing incidence with advancing age and no gender-related 
excess risk.
Conclusions: Salmonella enterica is an important emerging pathogen and regional determinants of risk merits further 
investigation.
Background
Salmonella enterica is a major cause of invasive infections
worldwide [1-7]. Although a wide range of serotypes may
cause human disease, they may be broadly grouped into
the typhoidal species that are specific human pathogens
and includes serotypes Typhi and Paratyphi, and other
serotypes that are primarily spread to humans from ani-
mal sources (non-typhoidal). In high income countries, a
major risk factor for acquiring typhoidal salmonella bac-
teremia is travel to an endemic region [8,9]. Foreign travel
is also a risk factor for acquiring non-typhoidal salmo-
nella infections, and several reports have highlighted the
spread of resistant species globally [10,11]. However,
non-typhoidal salmonella may frequently cause human
disease in high income countries and in these cases risk
factors include exposure to contaminated food, extremes
of age, and the presence of a number of co-morbid ill-
nesses [12-16].
In order to best establish the distribution and determi-
nants of an infectious disease, population-based studies
are optimal. This is because in these designs, selection
bias is minimized by inclusion of all cases of disease ful-
filling a case definition occurring among residents of a
defined population. In addition, because the population
at risk can be defined, incidence rates can be calculated
that facilitate comparison among different populations
and time periods. Only a few, relatively small studies have
investigated the epidemiology of S. enterica bacteremia at
the population level in single regions [17-19]. The objec-
tive of this study was to define the occurrence of S. enter-
ica bacteremia in a large international population and to
evaluate temporal and regional differences.
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Study protocol and definitions
This study utilized a multi-centre population-based
cohort design. All incident episodes of S. enterica bacter-
emia as defined by growth from one or more blood cul-
tures from a resident of the surveillance population
during January 1, 2000 to December 31, 2007 were identi-
fied. Year of culture, patient's age and gender were avail-
able for all cases and further microbiology and clinical
information such as admission status were collected from
all sites except Finland.
Bacteremia was defined as either hospital-onset (first
occurred > 2 days after hospital admission) or community
onset (first identified in community or within 2 days of
hospital admission). Non-typhoidal salmonella infections
were those exclusive of serotypes Typhi and Paratyphi.
Only the first episode of salmonella bacteremia serotype
per patient per year was included. Each center received
approval from their local ethical review committee.
Surveillance populations
Surveillance was conducted in Denmark, Finland, Aus-
tralia, and three regions in Canada under the auspices of
the International Bacteremia Surveillance Collaborative
[20]. Microbiology laboratory testing was performed by
each region according to their local procedures. Data
were abstracted from each region using a standardized
template. The Danish surveillance region was the North
Denmark Region using the previous boundaries of the
North Jutland County (population 495,000). Data were
obtained using the North Jutland Bacteremia Research
Database administered by the Department of Clinical
Microbiology at Aalborg Hospital [21]. Surveillance data
from Finland (population 5.3 million) was obtained using
the National Infectious Disease Register (NIDR) to which
all Finnish clinical microbiology laboratories report all
bacterial isolations from blood. The Canberra Region
(population 370,000) includes the city of Canberra within
the Australian Capital Territory and the satellite city of
Queanbeyan and several small surrounding rural towns
within the state of New South Wales. Surveillance was
conducted in three of the four microbiology laboratories
that are estimated to capture more than 95% of all posi-
tive blood cultures in the region [22]. The three Canadian
centers included Sherbrooke, Quebec, Victoria, British
Columbia, and Calgary, Alberta. Sherbrooke has a total
population of 152,000 residents and is served by a single
microbiology laboratory located in the Centre Hospitalier
Universitaire de Sherbrooke [23]. Data from the Victoria
area included the south local health area of the Vancou-
ver Island Health Authority (population 364,000), and
data were obtained from the regional microbiology labo-
ratory [20]. Laboratory based surveillance in the Calgary
Health Region (population 1.2 million) was conducted at
Calgary Laboratory Services that performs virtually all of
the blood culture testing among residents of the region
[24].
Data management and statistical analysis
Data from each of the surveillance centres was compiled
and analysed using Stata version 10.0 (Stata Corp, College
Station, TX). Prior to description of analysis, all continu-
ous variables were plotted using histograms to assess
their underlying distribution. Non-normally distributed
variables were reported as medians with inter-quartile
ranges (IQR). The incidence of salmonella bacteremia
was calculated by dividing the number of incident cases
by the surveillance population as determined by census
data from each of the surveillance areas. Incidence rates
overall and for non-typhoidal and typhoidal salmonella
bacteremia were directly standardized by age deciles and
gender to the 2007 27-country European Union (EU27)
population and reported as rates per 100,000 inhabitants
[20]. Because of the small numbers in many cells, crude
incidence rates were reported in sub-group analyses.
Risks in population groups were expressed as incidence
rate ratios (RR) and reported with 95% confidence inter-
vals.
Results
During the 8-year study, a total of 622 incident S. enterica
bacteremias occurred during 61,748,478 person-years of
surveillance; 370 (59%), 107 (17%), 78 (13%), 27 (4%), 21
(3%) and 19 (3%) cases were from Finland, Calgary, North
Denmark, Sherbrooke, Victoria, and Canberra, respec-
tively. Non-typhoidal isolates accounted for 490 (79%)
cases, and of the 132 typhoidal salmonella cases, 85 (64%)
were serotype Typhi and 47 (36%) were serotype Para-
typhi.
Incidence
The overall age and gender standardized annual inci-
dence rate was 1.02 per 100,000 population, and was 0.21
and 0.81 per 100,000 for typhoidal and non-typhoidal
bacteremia, respectively. The adjusted incidence rates
were markedly different among the regions and by salmo-
nella group as shown in Figure 1. There was moderate
year to year variability with an overall increase in crude
incidence observed in the latter years of the study related
principally to increasing rates of non-typhoidal salmo-
nella bacteremia as shown in Figure 2. The occurrence of
salmonella bacteremia varied during the months of the
year with the highest frequency in the late summer and
early fall months as shown in Figure 3.
Demographic factors
The overall risk of acquiring salmonella bacteremia var-
ied significantly by age, gender, and salmonella group as
shown in Figures 4a and 4b. Among non-typhoidal sal-
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advancing age and males were at significantly higher risk
(RR 1.62; 95% CI, 1.35-1.96; p < 0.0001). The excess risk
for non-typhoidal infections in males was most notable
among adults aged 70 to 89 (Figure 4a), with the markedly
increased incidence of non-typhoidal salmonella bactere-
mia observed among aged 90 and older attributable to an
excess number of cases in one centre (Denmark). In con-
trast, typhoidal salmonella bacteremias (Figure 4b)
showed a decreasing incidence with advancing age and
males were not at increased risk (RR 1.14; 95% CI, 0.80-
1.62; p = 0.47).
Clinical and microbiologic information
Further clinical and microbiology information was avail-
able for 252 cases. Among these, 234 (93%) were classi-
fied as community-onset and 204 (81%) were admitted to
hospital for a median length of stay of 7 days (IQR, 4-11
days). Of the 18 hospital-onset cases, all were non-
typhoidal serotypes and 10 (56%) were isolated during the
first 3-5 days of admission. Of the remaining eight, the
onset was 6, 8, 9 (2 cases), 15, 21 (2 cases) and 25 days
after admission.
Among the 252 cases with added details, 55 (22%) were
serotype Typhi, 20 (8%) were serotype Paratyphi, and 177
(70%) were non-typhoidal serotypes that included 36 S.
Enteritidis, 22 S. Heidelberg, 20 S. Typhimurium, 8 S.
Newport, 7 each of S. Dublin and S. Virchow, 6 S. Hadar,
4 each of S. Oranienburg and S. Saint Paul, 3 each of S.
Java, S. Panama, S. Poona, S. Choleraesuis, and S. San
Diego, 2 S. Arizonae, and one each of S. Muenster, S.
Infantis, S. Matadi, S. Schwarzengrund, S. Bournemouth,
S. Napoli, S. Bovismorbificans, S. Colindale, S. Haifa, S.
Corvallis and S. Agona. Other isolates not identified to
Figure 1 Age and gender standardized incidence of salmonella 
bacteremia by region and group, 2000-2007.
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Figure 2 Annual incidence of salmonella bacteremia, 2000-2007.
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Figure 3 Monthly occurrence of salmonella bacteremia (data 
from Finland not included). Month shown refers to month of the 
year (ie January = month 1) for northern hemisphere sites and adjusted 
by 6 months for opposite season in Australia (ie January = month 7).
Figure 4 Age and gender specific incidence of a) non-typhoidal 
and b) typhoidal salmonella bacteremia, 2000-2007.
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2 in 8, group D in 4, group B in 18, and were not reported
in 5 cases.
Susceptibility testing results were available for 246 iso-
lates. Reduced susceptibility to ampicillin was found in 52
(21%), and to ciprofloxacin in 7 (3%), and ceftriaxone in 7
(3%) cases. All isolates with reduced susceptibility to cef-
triaxone were from Sherbrooke and 6/7 ciprofloxacin
resistant isolates were from North Denmark.
Discussion
This study reports the first novel results of the evolving
International Bacteremia Surveillance Collaborative and
provides new population-based information on the epi-
demiology of salmonella bacteremia. Our collaborative
was initially formed in 2008 to address the lack of coordi-
nated population based study of invasive bacterial dis-
eases internationally [20]. Our present results highlight
the value of such an initiative. The more than 60 million
combined patient years of observation enabled us to
study a large number of cases in low incidence areas. In
addition, we were able to directly calculate the incidence
of disease because in our surveillance areas all cases were
included (sampling was not performed) and we had well-
defined populations at risk for denominator data. This
contrasts with non-population based studies such as hos-
pital-based case series where sampling bias is a poten-
tially major concern and the population at risk is rarely
definable for community-onset disease [25]. Further-
more, by age and gender standardization to the EU27
population, we were able to meaningfully compare rates
of disease in our surveillance regions. We observed that
salmonella bacteremia is a relatively uncommon cause of
bacteremia in our populations, but that considerable
demographic and regional differences in occurrence
exist.
The observations of significant differences among
regions and by species group are important and novel.
While we believe these represent true differences in inci-
dence, a number of other factors could potentially at least
in part explain these observations. Since the risk for sal-
monella bacteremia is influenced by age and gender,
where populations differ in demographic structure then
crude incidence rates may be expected to differ. However,
we controlled for this possibility by age and gender stan-
dardizing our overall incidence rates. A second potential
issue is that there may have been different rates of case
ascertainment (identifying all culture-positive cases
among residents) among our surveillance regions. While
in some cases ascertainment was expected to approach or
equal 100% such as with the national mandatory report-
ing system in Finland, this was not strictly the case in
every other region [20]. However, all the other surveil-
lance areas in this study are highly captive and estimated
to be 95% or higher, such that the 2-3 fold differences in
rates could not be explained by these small potential dif-
ferential rates of ascertainment. A third possibility is that
there may have been differences in the culturing practices
among regions. This arises if the decision to sample blood
for culture is significantly different among regions, and it
may be expected that areas that sample more frequently
may observe higher numbers of culture-positive cases. It
is important to note that in all of our study regions the
cost of blood culturing is fully publicly funded and avail-
able to all residents irrespective of financial means. While
we cannot directly assess the issue of differential blood
culturing pratices among our regions as we do not have
data on negative cultures, it is notable that in previous
individual publications on other common species causing
bloodstream infections such as Escherichia coli and
Staphylococcus aureus, similar crude incidence rates were
reported [22-24,26,27]. Although we may speculate as to
why the incidence of salmonella bacteremia differs so
greatly among our regions, further studies are needed to
explore factors such as travel, food preparation practices,
agricultural, and other factors [8,28].
Our observation of increased risk for salmonella bacte-
remia during the summer has been previously well docu-
mented [17,29,30], and has been proposed to be due to
increased travel abroad and lax food preparation related
to outdoor cooking in that season. Several previous stud-
ies have documented increased colonization rates with
salmonella species among food animals during the sum-
mer months [31-33]. Our observation of an increased risk
for non-typhoidal salmonella bacteremia with advancing
age is likely at least in part due to a higher prevalence of
co-morbid illnesses in the older age group that predis-
pose to bacteremia risk [25,34]. The excess population
risk in males for non-typhoidal salmonella bacteremia is a
novel finding. We speculate that this may be due to agri-
cultural or diet exposure in males. Typhoidal salmonella
bacteremia occurred in younger individuals and no gen-
der-associated risk was evident. We suspect that this may
reflect a greater rate of foreign travel to exotic typhoidal
salmonella endemic regions in the younger age groups or
possibly may reflect younger immigrant populations.
However, while we speculate reasons as to why age and
gender may modify risk, we do not have empiric data to
support these suspicions. The determinants of increased
risk for salmonella bacteremia in our surveillance regions
merits further prospective investigation.
While this study benefits from the large, multi-national,
population-based design, there are some limitations that
merit discussion. The surveillance regions involved in
this study are high income Western countries with largely
publicly funded health systems. These results should
therefore not be generalized to other dissimilar jurisdic-
tions especially low income countries and tropical areas.
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the most common bacterial pathogens and may be
responsible for as many as one-half of all bacteremias
[6,35,36] whereas they typically represent ≤1% in high
income countries [18,37]. Incidence rates for typhoid in
the developing world, especially the Indian subcontinent,
may be several orders of magnitude higher than that
reported here [7,36]. Second, the information that we col-
lected was retrospective. While we used common criteria
for inclusion procedures and data were abstracted using a
standardized template, the routine laboratory testing pro-
cedures and methods of clinical data collection varied
somewhat site-by-site. For example, only basic informa-
tion was available from Finnish cases, and microbiology
and clinical details from the other centers were deter-
mined using the local data sets and procedures. These
included prospective review in Denmark and electronic
records review and/or database extraction in other sites.
In addition, ideally isolates would have been serotyped
and tested for antimicrobial susceptibility in a single cen-
tralized laboratory. Finally, it would have been useful to
have added information on other potential risk factors
such as food and animal exposures, international travel,
and co-morbid illness.
Conclusions
In summary, in this multi-national collaborative study we
report the epidemiology of salmonella bacteremia and
find regional and temporal differences in occurrence.
Further studies designed to define the determinants of
risk for acquiring salmonella bacteremia are warranted.
This report highlights the benefit of international co-
operation in bacteremia surveillance and sets the stage
for future collaborative studies.
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